Review revenue & brand developments and align on targets, tactics, and strategies across multiple men’s health brands. Foster collaboration between sales reps and management to deliver a strong finish for Q4, celebrate successes and recognize teamwork and individual performance.

A top 10 pharmaceutical manufacturer aims to train 100 sales representatives on a new indication for a leading biologic therapy before a national launch meeting. Objectives include facilitating personal introductions, engaging representatives, and avoiding distractions and dry content from traditional web platforms. The plan is to consolidate a 4-week training program into a 2-week curriculum, delivered by 3 in-studio presenters and 2 remote presenters over 16 training sessions.

A top 10 pharmaceutical manufacturer is collaborating on Multiple Sclerosis (MS) therapeutic areas. The objective is to discuss strategies related to MS clinical trials, physician messaging, patient engagement, and new assets. The target audience comprises 25 members of the MS Franchise Team, including 23 on-wall participants and 2 off-wall participants from the sales and marketing departments.

A global top 10 pharmaceutical manufacturer aims to train its rheumatology sales force on new healthcare provider segmentation for pre-call planning and customized messaging. The training will be cost-effective, engaging, interactive, and will include role-playing to ensure application of learnings. The target audience consists of 178 on-wall sales representatives and 17 off-wall executives and home office personnel.

A global top 10 pharmaceutical company aims to educate hard-to-access healthcare providers, including dermatologists and rheumatologists, on helping patients gain access to prescribed therapies by identifying available resources and services, and on effectively presenting new data.

A top 20 pharmaceutical manufacturer aims to educate 180 lung cancer franchise sales representatives on the latest clinical data and treatment advances in lung cancer. The training will use a live, interactive format with a multidisciplinary panel of key opinion leaders (KOLs) to enhance engagement, replacing previous radio and pre-recorded web programs.